Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial

comparing Bevacizumab to Ranibizumab in Age-related Macular Degeneration (BRAMD) Trial Research Group

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science